Bosentan
Generic name: Bosentan
Brand names: Tracleer
Drug class:
Agents for pulmonary hypertension
Usage of Bosentan
Bosentan lowers blood pressure in your lungs, helping your heart pump blood more efficiently.
Bosentan is used to treat pulmonary arterial hypertension (PAH) in adults and children who are at least 3 years old. It improves your ability to exercise and prevents your condition from getting worse.
Bosentan is available only under a special program from a certified pharmacy. You must be registered in the program and understand the risks and benefits of taking this medication.
Bosentan may also be used for purposes not listed in this medication guide.
Bosentan side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Seek medical treatment if you have a serious drug reaction that can affect many parts of your body. Symptoms may include: skin rash, fever, swollen glands, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes.
Bosentan may cause serious side effects. Call your doctor at once if you have:
Common side effects of bosentan may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Bosentan
You should not use bosentan if you are allergic to it, or if you are pregnant or might become pregnant during treatment.
Some medicines can cause unwanted or dangerous effects when used with bosentan. Your doctor may change your treatment plan if you also use:
Tell your doctor if you have ever had:
Do not use bosentan if you are pregnant or think you might be pregnant. This medicine can cause serious birth defects. Tell your doctor right away if you miss a menstrual period or think you may have become pregnant during treatment.
You will need to have a negative pregnancy test before starting this treatment. You will be re-tested every month during your treatment, and 1 month after you stop taking this medicine.
Even if you are not planning a pregnancy, you are considered able to become pregnant if:
While taking bosentan and for at least 30 days after your last dose, you must use a highly effective form of birth control or two methods together.
Bosentan comes with patient instructions about acceptable forms of birth control to use while taking this medicine. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
If you are the parent or caregiver of a female child taking this medicine, talk to the child's doctor once you notice any signs of puberty (breast development or pubic hair), even if menstrual periods have not yet begun.
Bosentan can decrease sperm count and may affect fertility in men (your ability to have children).
You should not breast-feed while using this medicine.
Relate drugs
- Adcirca
- Alyq
- Ambrisentan
- Bosentan
- Epoprostenol
- Flolan
- Iloprost
- Iloprost inhalation
- Letairis
- Liqrev
- Macitentan
- Opsumit
- Orenitram
- Orenitram Titration Kit Month 1
- Orenitram Titration Kit Month 2
- Orenitram Titration Kit Month 3
- Remodulin
- Remodulin injection
- Revatio
- Revatio (Sildenafil Intravenous)
- Revatio (Sildenafil Oral)
- Selexipag (Intravenous)
- Selexipag (Oral)
- Selexipag oral/injection
- Tracleer
- Treprostinil
- Treprostinil (Oral)
- Treprostinil inhalation
- Treprostinil injection
- Tyvaso
- Tyvaso DPI
- Tyvaso DPI Maintenance Kit inhalation
- Tyvaso DPI Titration Kit inhalation
- Tyvaso Starter Kit (Institutional) inhalation
- Uptravi
- Uptravi (Selexipag Intravenous)
- Uptravi (Selexipag Oral)
- Veletri
- Ventavis
How to use Bosentan
Usual Adult Dose for Pulmonary Hypertension:
Initial dose: 62.5 mg orally twice a day for 4 weeksMaintenance dose: Following initial dose, increase to 125 mg orally twice a dayComments:-Doses above 125 mg twice a day did not appear to confer additional benefit sufficient enough to offset increased risk of hepatotoxicity.Use: For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and to decrease clinical worsening.
Usual Pediatric Dose for Pulmonary Hypertension:
3 to 12 years:4 kg to 8 kg: 16 mg orally twice a dayGreater than 8 kg to 16 kg: 32 mg orally twice a dayGreater than 16 kg to 24 kg: 48 mg orally twice a dayGreater than 24 kg to 40 kg: 64 mg orally twice a dayGreater than 12 years:-Less than 40 kg: 62.5 mg orally twice a day-Greater than 40 kg: 62.5 mg orally twice a day for 4 weeks, then increase to 125 mg orally twice a dayUse: For use in pediatric patients 3 years or older with idiopathic or congenital PAH to improve pulmonary vascular resistance, which is expected to result in an improvement in exercise ability
Warnings
Do not use bosentan if you are pregnant or think you might be pregnant. You will need to take a pregnancy test before, during, and after treatment with bosentan. Use highly effective birth control to prevent pregnancy while using bosentan and for at least 30 days after your last dose.
Certain other medicines can interact with bosentan and should not be used at the same time. Tell your doctor about all your current medicines.
Bosentan can cause severe liver problems. Your liver function will need to be tested often.
Call your doctor right away if you have have signs of liver problems such as nausea, vomiting, fever, upper stomach pain, tiredness, or jaundice (yellowing of the skin or eyes).
Bosentan is available only from a certified pharmacy under a special program.
What other drugs will affect Bosentan
Tell your doctor about all your other medicines, especially:
This list is not complete and many other drugs may affect bosentan. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions